Skip to content

The NOxBOXi Nitric Oxide Delivery System

by Praxair, Inc.

510(k) K201339

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

4 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 11 Oct 2026. What this means

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK201339 Date19 Jun 2020ClearedStatusActive

Recalls

4 recalls · 4 ongoing · FDA

    • Ongoing Z-3306-2026 FDA Class II initiated 14 Sep 2026

    Potential for irregular oxygen readings due to a manufacturing issue affecting certain oxygen sensors.

    • Ongoing Z-3165-2026 FDA Class II initiated 19 Aug 2026

    Potential for oxygen tubing leaks due to failure of the tubing or tubing connection, which may lead to oxygen desaturation.

    • Ongoing Z-0028-2026 FDA Class I initiated 9 Sep 2025

    Fluctuations may be more likely to occur if the total flow through the device sensor (used by the device to determine flow) is less than the minimum device requirement of 0.5 LPM. In addition, dose fluctuations have been observed when Bunnel LifePulse HFJV system or conventional ventilators have the following device settings: low service pressures generally less than 3.0 PSI, a pressure difference greater than 5.0cm H2O; or at breath per minute rates of 300 (5 Hz).

    • Ongoing Z-0029-2026 FDA Class I initiated 9 Sep 2025

    The unexpected internal fault / system diagnostic error to result when a rapid succession of button selections is made to the user interface without waiting for the device to respond to user prompts.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MRN
Device Class
Class II
Regulation
21 CFR Part 868.5165
Advisory Committee
Anesthesiology
FDA Decision
SESE Substantially Equivalent

Other devices from Praxair, Inc.